The lobbying effort of the patent 'industry' -- and its largest beneficiaries -- paints its own perks as something that's intended for their small/minuscule competitors (whom they actually attempt to misrepresent and crush)
The patent microcosm is attempting to buy laws that supersede the US Supreme Court (SCOTUS) and remove/weaken U.S.C. § 101 as well as PTAB while their blogs and sponsored 'articles' serve as lobbying vehicles
Odd rants which misuse common law and ignore alleged Fair Use (and misinterpretation of copyright law, for censorship purposes) would have people believe that we're wrong; but it's more likely that the person in question is jealous, insecure, or offended by our stance on patent scope, which is very
The Canadian government has announced amendments to its regulations concerning patented drugs that it says will make medicines more affordable. According to Health Canada, these changes will save Canadians $13.2 billion (US $9.97 billion) over the next decade.
"With fraudulent and suspicious activity before the #USPTO on the rise, the question arises of how the USPTO is leveraging its disciplinary authority to ensure that it continues to fulfill its mission"
The Federal Circuit has asked USPTO director Andrei Iancu to explain what deference should be afforded to a panel that determines whether patent disputes are precedential – a move which, lawyers say, could affect future disputes
Through strategic claim drafting, oil and gas companies can overcome Section 101 and obtain patents covering digital technologies and AI, say Charles Collins-Chase, Jennifer Roscetti and Paul Townsend of Finnegan
By Kevin E. Noonan -- The Federal Circuit again reviewed a determination of infringement under the doctrine of equivalents, in this instance by the International Trade Commission (ITC), again finding that one of the Supreme Court's exceptions to the preclusive effects of prosecution history estoppel (the "tangential relationship" test) applied, and affirmed the ITC's finding of infringement under the doctrine. Ajinomoto petitioned the International Trade Commission (ITC) under Section 337 (19 U.S.C. § 1337) for an exclusion order against CJ Cheiljedang for importing animal feed-grade L-tryptophan amino acid products produced by several different strains of Escherichia coli and that infringed...
Just because the #uspto may be willing to give you a #patent #monopoly on some algorithm doesn't mean you can sue (without risk of paying the legal fees of the accused, too). #patents on algorithms are kaput in the US.